Essa Pharma's common stock is $280M.
Get informed when a big investor buys or sells
+ FollowLatest change versus the prior comparable period (same company). Positive growth indicates new issuance/dilution; negative growth indicates reductions/buybacks.
Essa Pharma (EPIX) currently reports a common stock of $280M as of June 2025. That compares with $280M in the prior-year period — up 0.0% year over year. Use the charts on this page to explore Essa Pharma's common stock history and peer comparisons.
Essa Pharma's common stock was unchanged from $280M to $280M — essentially flat versus a year earlier (period ending June 2025). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.
Essa Pharma reported $280M in common stock as of June 2025. That compares with $280M in the prior-year period — up 0.0% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.
Start with the current common stock of $280M, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Essa Pharma, and consider following EPIX for alerts when major investors trade the stock.
Essa Pharma is classified in the Healthcare sector. On common stock, it currently shows $280M. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing EPIX with unrelated industries.